PRESS RELEASE published on 10/21/2025 at 18:49, 1 month 14 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma annonce une validation historique dans la revue NATURE confirmant la causalité génétique de l'apolipoprotéine A-I (ApoA-I) dans le sepsis. Une avancée majeure dans le traitement de la septicémie Validation Historique ABIONYX Pharma Nature Septicémie Causalité Génétique
BRIEF published on 10/06/2025 at 15:00, 1 month 30 days ago Franchissement de seuil par la Caisse des dépôts et consignations dans ABIONYX PHARMA Droits De Vote Franchissement De Seuil CDC Bpifrance ABIONYX
BRIEF published on 10/06/2025 at 15:00, 1 month 30 days ago Threshold crossing by the Caisse des dépôts et consignations in ABIONYX PHARMA Voting Rights CDC Threshold Crossing Bpifrance ABIONYX
BRIEF published on 10/06/2025 at 14:56, 1 month 30 days ago Threshold Crossing by Bpifrance at ABIONYX PHARMA Voting Rights Actions Threshold Crossing Bpifrance ABIONYX Pharma
BRIEF published on 10/06/2025 at 14:56, 1 month 30 days ago Franchissement de Seuil par Bpifrance chez ABIONYX PHARMA Droits De Vote Franchissement De Seuil Actions Bpifrance ABIONYX Pharma
PRESS RELEASE published on 10/06/2025 at 14:55, 1 month 30 days ago Franchissement de seuil Déclaration de franchissement de seuil pour ABIONYX PHARMA par la Caisse des dépôts et consignations via Bpifrance Participations Déclaration Franchissement De Seuil Bpifrance Caisse Des Dépôts ABIONYX Pharma
PRESS RELEASE published on 10/06/2025 at 14:51, 1 month 30 days ago Franchissement de seuil Déclaration de franchissement de seuil par Bpifrance concernant ABIONYX PHARMA sur Euronext Paris, le 29 septembre 2025 Euronext Paris Franchissement De Seuil Bpifrance ABIONYX Pharma 29 Septembre 2025
BRIEF published on 09/25/2025 at 20:21, 2 months 9 days ago ABIONYX Pharma : Résultats financiers du premier semestre 2025 Résultats Financiers Recherche Et Développement Trésorerie Plan France 2030 ABIONYX Pharma
BRIEF published on 09/25/2025 at 20:21, 2 months 9 days ago ABIONYX Pharma: Financial results for the first half of 2025 Financial Results Research And Development Treasury France 2030 Plan ABIONYX Pharma
PRESS RELEASE published on 09/25/2025 at 20:16, 2 months 9 days ago Inside Information / News release on accounts, results ABIONYX Pharma announces its 2025 half-year financial results, including revenue of €2.1 million and ongoing initiatives in biotech innovation. Company receives government support for sepsis research Revenue Biotech Innovation ABIONYX Pharma 2025 Financial Results Sepsis Research
Published on 12/05/2025 at 15:00, 32 minutes ago Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Published on 12/05/2025 at 14:00, 1 hour 32 minutes ago Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 1 hour 32 minutes ago Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 12 hours 57 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 15:05, 27 minutes ago Seegene Establishes French Subsidiary to Expand European Footprint
Published on 12/05/2025 at 14:22, 1 hour 10 minutes ago EQS-Adhoc: Jungheinrich AG: Jungheinrich expects to complete sale of its Russian subsidiary in 2026 and adjusts forecast for the 2025 financial year
Published on 12/05/2025 at 14:16, 1 hour 16 minutes ago Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Published on 12/05/2025 at 14:10, 1 hour 22 minutes ago The Kingdom of Saudi Arabia Launches a New Official Platform, "Saudi Properties", Ahead of the Non-Saudi Property Ownership Law
Published on 12/05/2025 at 13:45, 1 hour 47 minutes ago BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 15:10, 21 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 21 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 1 hour 34 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 6 hours 47 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 6 hours 47 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
